Among these genes, Dyrk1a (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A) and Ripply3 (Ripply Transcriptional Repressor 3) seemed promising targets for CF in DS. The gene discussed is RIPPLY3; the disease is Dravet syndrome.